Filter
1064
Filtered Results: 1064
Text search:
rifampicina
Featured
Recommendations
127
New Publications
284
Language
Document type
No document type
692
Guidelines
155
Studies & Reports
87
Manuals
54
Strategic & Response Plan
29
Training Material
19
Fact sheets
17
Situation Updates
5
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
58
India
58
Eastern Europe
32
South Africa
25
Nepal
23
Latin America and the Carribbean
22
Kenya
19
Colombia
16
Tanzania
16
Argentina
16
Peru
15
Nigeria
14
Namibia
14
Germany
13
Paraguay
13
Bangladesh
13
Uganda
13
Indonesia
13
Global
12
Ethiopia
12
Zambia
12
El Salvador
11
Rwanda
11
Malawi
10
Bolivia
10
Brazil
10
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Ukraine
8
Senegal
7
Mozambique
7
Asia
7
Africa
6
Congo, Democratic Republic of
6
Russia
6
Tajikistan
5
Cameroon
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Benin
4
Chile
4
Venezuela
4
Botswana
4
Lesotho
3
Ghana
3
Sierra Leone
3
Burkina Faso
3
Zimbabwe
3
Georgia
3
Bhutan
3
Madagascar
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Haiti
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Liberia
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Tunisia
1
Spain
1
Lebanon
1
Vietnam
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
434
Clinical Guidelines
137
Public Health
22
Women & Child Health
22
Capacity Building
17
Pharmacy & Technologies
14
Key Resources
6
Toolboxes
TB
499
HIV
93
NTDs
48
Pharmacy
36
AMR
34
Refugee
16
Polio
12
COVID-19
8
Ebola
5
Caregiver
5
Mental Health
4
Conflict
4
Global Health Education
3
Rapid Response
2
Natural Hazards
1
Planetary Health
1
Zika
1
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This is the first edition of Empiric Antibiotic Guidelines, as a guidance to all medical practitioners at North Okklapa General & Teaching Hospital.
Antibiotics are critical in the management of infection and can have a significant impact in reducing morbidity and mortality. Emerging antimicrobia...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
L’ulcère de Buruli, une infection causée par Mycobacterium ulcerans, touche plus de 33 pays dans le monde, mais un peu moins de la moitié seulement de ces pays communiquent régulièrement des données sur la maladie à l’OMS.
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
Recommendations on the initiation and continuing use of nine common types of contraceptive methods are covered by the tool. In addition to looking at individual medical conditions or characteristics, users may also easily combine multiple conditions or characteristics and view the guidance on each c...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
